Live coverage | BIO 2025

BIO International 2025

Innovation, speed and scale to empower the future of drug development

Our values

Maximizing efficiency and reducing bottlenecks across the drug development continuum is critical to delivering life-changing therapies to patients. This is why flexibility – in strategy and solutions – and the power of collaboration are foundational to accelerating drug development, from research through commercialization.

 

This year at BIO International Convention, we’re showcasing how, through Accelerator™ Drug Development, we tailor our solutions to support our biotech and biopharma customers’ unique needs. We integrate our proven expertise, global reach and broad capabilities – from bioprocessing to clinical supply and clinical research services and manufacturing – to drive the innovation, productivity and scalability that empower the future of drug development.

 

Watch here for highlights from Thermo Fisher’s BIO International panel discussions on topics ranging from industry trends and sustainability to the power of partnerships and how to break into biotech.  

How Thermo Fisher Scientific combats climate change on its path to net zero

"As a company, we realize that investing in fossil fuel infrastructure now could lock us into a future of high emissions that is incompatible with our climate goals. Acting with urgency is not just a moral imperative—it’s also smart business," says Matthew Yamatin in his interview about his passion for sustainability and how transitioning to a low-carbon economy will create both challenges and opportunities for innovation and growth at Thermo Fisher.

Coming soon

A news story highlighting important data from an exciting academic study on drug development.

00
Days
00
Hours
00
Minutes
00
Seconds

Thought leadership

Hear from our CEO before heading to BIO International

Perspectives: The power of partnerships in cell, gene and advanced therapies

Cell and gene therapies hold immense promise, but the journey from research to patient care is fraught with challenges, including complex manufacturing, regulatory hurdles, and significant investments.

Navigating these complexities reveals a fundamental truth: no single entity can succeed alone, writes Betty Woo, vice president of cell, gene and advanced therapies at Thermo Fisher.

News from BIO International

Michael Cohen, senior director, environmental sustainability, clinical research, Thermo Fisher, joins a panel that will explore how companies can align with growing regulations and expectations, while minimizing risk.

Details: Shaping Strategies for Impact, Resilience and Lasting Value

cohen_500x500circle - 1

Karen Nelson, Ph.D., chief scientific officer, Thermo Fisher, participates in discussions about innovation, leadership and elevating community across life sciences.

Details: BLOC: Innovation in a Changing Environment: Adaptive Strategies

nelson_500x500circle - 1

Betty Woo, vice president, cell, gene and advanced therapies, Thermo Fisher, takes a deep dive into the power of strategic partnerships, the role of national collaboration and the impact of innovation hubs.

Details: The Power of Partnerships: Why Long-Term Strategic Collaborations Matter

woo_500x500circle - 1

Join MassBio CEO Kendalle Burlin O’Connell, Governor Maura Healey, and Thermo Fisher Scientific Chairman, President & CEO Marc Casper for a compelling fireside chat exploring why Massachusetts remains the global epicenter for the life sciences. This conversation will reflect on the Commonwealth’s deep industry roots, dynamic innovation ecosystem, and unmatched talent pipeline.

Details: Visit the Massachusetts Pavilion at BIO 2025 - MLSC

Ben Castro, vice president and general manager, large molecule, drug substance, Thermo Fisher, will moderate an exciting discussion on the latest industry trends in drug development.

ben_castro_300x300circle - 1

Daniella Cramp, senior vice president and president, bioproduction, Thermo Fisher, joins a discussion on driving better outcomes for patients.

Details: BIO 2025 Pavilion #553 – Maryland Tech Council

Rose Blackburne, vice president, head of population science strategy & women's health, clinical research, Thermo Fisher, joins a panel discussion that will provide guidance on how to navigate entry into the biotech industry.

Details: Breaking into Biotech

blackburne_500x500circle - 1

Back to top